Your browser doesn't support javascript.
loading
SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: Recommendations from the French society for ImmunoTherapy of Cancer (FITC).
Gauci, Marie-Léa; Coutzac, Clélia; Houot, Roch; Marabelle, Aurélien; Lebbé, Céleste.
Affiliation
  • Gauci ML; Université de Paris, AP-HP Dermatology, INSERM U976, Saint Louis Hospital, Paris, France. Electronic address: marie-lea.gauci@aphp.fr.
  • Coutzac C; Centre Léon Bérard, Cancer Research Center of Lyon (CRCL), Lyon, France.
  • Houot R; Centre Hospitalier Universitaire de Rennes, Service D'Hématologie Clinique, Rennes, France.
  • Marabelle A; Gustave Roussy, Université Paris-Saclay, Département D'Innovation Thérapeutique et D'Essais Précoces, Villejuif, France; Gustave-Roussy, Université Paris-Saclay, INSERM U1015 & CIC1428, Villejuif, France.
  • Lebbé C; Université de Paris, AP-HP Dermatology, INSERM U976, Saint Louis Hospital, Paris, France.
Eur J Cancer ; 148: 121-123, 2021 05.
Article in En | MEDLINE | ID: mdl-33743480
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy, Adoptive / Antineoplastic Agents, Immunological / Immune Checkpoint Inhibitors / COVID-19 Vaccines / COVID-19 / Neoplasms Type of study: Guideline Limits: Humans Country/Region as subject: Europa Language: En Journal: Eur J Cancer Year: 2021 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy, Adoptive / Antineoplastic Agents, Immunological / Immune Checkpoint Inhibitors / COVID-19 Vaccines / COVID-19 / Neoplasms Type of study: Guideline Limits: Humans Country/Region as subject: Europa Language: En Journal: Eur J Cancer Year: 2021 Document type: Article